Callan Family Office’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$738K	Buy	+47,762	New	+$738K	0.02%	467
2025 Q1	–	Sell	-19,924	Closed	-$264K	–	638
2024 Q4	$264K	Buy	+19,924	New	+$264K	0.02%	523